ArticleFrontiers in microbiology2018
High Prevalence of
Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed.
- Phenotypic and genomic characterization of NDM-producingMicrobiology spectrum · 2026Article
- An integrated phenotypic and genomic approach to characterize MBL-producing Enterobacterales strains circulating in a Sicilian transplant center.Microbiology spectrum · 2026Article
- Prevalence, multidrug resistance patterns, and carbapenemase-encoding genes of carbapenemase-producingSAGE open medicine · 2026Review
- Molecular epidemiology and genomic evolution mechanism of carbapenemase-resistantFrontiers in microbiology · 2026Article
- Prevalence and molecular characterization of multi-drug and extreme drug resistant Escherichia coli in companion animals in Bangladesh.Scientific reports · 2025Article
- Pathogenesis and Immunomodulation of Urinary Tract Infections Caused by UropathogenicMicroorganisms · 2025Review
- Predominance ofMedicina (Kaunas, Lithuania) · 2024Article
- Epidemiological and genomic characteristics of global blaNDM-carrying Escherichia coli.Annals of clinical microbiology and antimicrobials · 2024Article
- Fluorescently Modified NDM-1: A Versatile Drug Sensor for RapidACS omega · 2024Article
- Review
- Genomic characterization of aFrontiers in cellular and infection microbiology · 2024Article
- Sub-MIC antibiotics increased the fitness cost of CRISPR-Cas inFrontiers in microbiology · 2024Article
- New Delhi metallo-β-lactamases among extensively drug-resistant clinical isolates from Lahore, Pakistan.Future microbiology · 2024Article
- Identification of diverse antibiotic resistant bacteria in agricultural soil with HEnvironmental microbiome · 2023Article
- pKpQIL-like plasmid contributes to the dissemination ofIranian journal of microbiology · 2023Article
- Molecular surveillance reveals the emergence and dissemination of NDM-5-producingEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2023Article
- Characterization of NDM-5-ProducingGenes · 2023Article
- Genomic Epidemiology Insights on NDM-Producing Pathogens Revealed the Pivotal Role of Plasmids onMicrobiology spectrum · 2022Article
- Characterization and Public Health Insights of the New Delhi Metallo-β-Lactamase-ProducingMicroorganisms · 2022Article
- Phylogenetic diversity and mutational analysis of New Delhi Metallo-β-lactamase (NDM) producingSaudi journal of biological sciences · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The continuous emergence of carbapenem-resistant
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.